WELLESLEY HILLS, Mass., Sept. 14 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM - News), a specialty pharmaceutical company that develops and seeks to commercialize pharmaceutical products based on proprietary drug delivery technologies, has retained The Investor Relations Group, Inc. (IRG), a full-service investor relations firm, to serve as its new investor relations and corporate communications agency.
